A detailed history of Winslow Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Winslow Asset Management Inc holds 21,378 shares of AMGN stock, worth $6.89 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares
21,378
Previous 21,921 2.48%
Holding current value
$6.89 Million
Previous $6.23 Million 7.17%
% of portfolio
1.32%
Previous 1.17%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$262.75 - $319.31 $142,673 - $173,385
-543 Reduced 2.48%
21,378 $6.68 Million
Q1 2024

May 02, 2024

SELL
$268.87 - $324.56 $3,764 - $4,543
-14 Reduced 0.06%
21,921 $6.23 Million
Q4 2023

Feb 16, 2024

BUY
$255.7 - $288.46 $64,692 - $72,980
253 Added 1.17%
21,935 $6.32 Million
Q3 2023

Nov 07, 2023

SELL
$218.65 - $271.46 $134,469 - $166,947
-615 Reduced 2.76%
21,682 $5.83 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $200,128 - $236,647
-934 Reduced 4.02%
22,297 $4.95 Million
Q1 2023

May 03, 2023

SELL
$225.79 - $275.2 $11,515 - $14,035
-51 Reduced 0.22%
23,231 $5.62 Million
Q4 2022

Jan 23, 2023

SELL
$229.03 - $291.01 $19,925 - $25,317
-87 Reduced 0.37%
23,282 $6.12 Million
Q3 2022

Nov 08, 2022

SELL
$224.46 - $253.15 $9,651 - $10,885
-43 Reduced 0.18%
23,369 $5.27 Million
Q2 2022

Aug 03, 2022

BUY
$230.71 - $256.74 $60,907 - $67,779
264 Added 1.14%
23,412 $5.7 Million
Q1 2022

May 09, 2022

SELL
$219.27 - $242.57 $53,940 - $59,672
-246 Reduced 1.05%
23,148 $5.6 Million
Q4 2021

Feb 07, 2022

BUY
$198.88 - $227.6 $32,218 - $36,871
162 Added 0.7%
23,394 $5.26 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $55,190 - $64,662
-260 Reduced 1.11%
23,232 $4.94 Million
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $172,382 - $191,245
738 Added 3.24%
23,492 $5.73 Million
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $64,131 - $74,735
289 Added 1.29%
22,754 $5.66 Million
Q4 2020

Feb 01, 2021

SELL
$216.38 - $257.67 $47,170 - $56,172
-218 Reduced 0.96%
22,465 $5.17 Million
Q3 2020

Nov 10, 2020

SELL
$234.65 - $260.95 $26,984 - $30,009
-115 Reduced 0.5%
22,683 $5.77 Million
Q2 2020

Aug 11, 2020

SELL
$197.81 - $242.74 $30,264 - $37,139
-153 Reduced 0.67%
22,798 $5.38 Million
Q1 2020

May 12, 2020

BUY
$182.24 - $241.7 $71,255 - $94,504
391 Added 1.73%
22,951 $4.65 Million
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $58,276 - $74,905
308 Added 1.38%
22,560 $5.44 Million
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $665,622 - $797,554
-3,823 Reduced 14.66%
22,252 $4.31 Million
Q2 2019

Jul 29, 2019

SELL
$166.7 - $195.41 $386,243 - $452,764
-2,317 Reduced 8.16%
26,075 $4.81 Million
Q1 2019

May 10, 2019

BUY
$180.87 - $203.88 $15,373 - $17,329
85 Added 0.3%
28,392 $5.39 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $25,689 - $29,988
144 Added 0.51%
28,307 $5.51 Million
Q3 2018

Oct 18, 2018

BUY
$185.29 - $208.89 $2,594 - $2,924
14 Added 0.05%
28,163 $5.84 Million
Q2 2018

Jul 13, 2018

BUY
$166.05 - $186.51 $121,548 - $136,525
732 Added 2.67%
28,149 $5.2 Million
Q1 2018

Apr 26, 2018

BUY
$169.43 - $198.0 $3.18 Million - $3.72 Million
18,777 Added 217.33%
27,417 $4.67 Million
Q4 2017

Jan 11, 2018

BUY
$168.79 - $188.59 $1.46 Million - $1.63 Million
8,640
8,640 $1.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Winslow Asset Management Inc Portfolio

Follow Winslow Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Asset Management Inc with notifications on news.